The management of attentiondeficit hyperactivity disorder in children: updated 2017

N Schellack, AK Chigome, JC Meyer - SA Pharmaceutical Journal, 2017 - journals.co.za
Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder that is
commonly diagnosed and involves the academic, social and family functioning of the child …

The management of attention deficit-hyperactivity disorder in children: Evidence-based pharmacy practice

N Schellack, H Meyer - SA Pharmaceutical Journal, 2012 - journals.co.za
Attention deficit-hyperactivity disorder (ADHD) involves the academic, social and family
functioning of the child. Prevalence of the disorder is approximately 5.3% worldwide and …

Pharmacological management of attention-deficit hyperactivity disorder in adolescents: Special considerations

P Hazell - CNS drugs, 2007 - Springer
Approximately one-half of children medicated for attention-deficit hyperactivity disorder
(ADHD) will continue to experience sufficient impairment during adolescence to warrant the …

Background, clinical features and treatment of attention deficit hyperactivity disorder in children

N Warikoo, SV Faraone - Expert opinion on pharmacotherapy, 2013 - Taylor & Francis
Introduction: Attention deficit hyperactivity disorder (ADHD) is an early onset, clinically
heterogeneous, complex neurobiological disorder, defined by symptoms of inattention and …

The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: protocol for a systematic review and …

F Catalá-López, B Hutton, A Núñez-Beltrán… - Systematic reviews, 2015 - Springer
Background Attention deficit hyperactivity disorder (ADHD) is one of the most common
neurodevelopmental disorders of children and adolescents, with a significant impact on …

Efficacy and safety of drugs for attention deficit hyperactivity disorder in children and adolescents: a network meta-analysis

SCOS Padilha, S Virtuoso, FS Tonin… - European child & …, 2018 - Springer
The aim of this study is to gather evidence of head-to-head double-blind randomized-
controlled trials on the efficacy and safety of available treatments for attention deficit …

Drug class review: pharmacologic treatments for attention deficit hyperactivity disorder: final update 4 report

MS McDonagh, K Peterson, S Thakurta, A Low - 2012 - europepmc.org
Purpose Attention deficit hyperactivity disorder (ADHD) affects children and adults and is
treated with both pharmacologic and nonpharmacologic interventions. Multiple drugs are …

Pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: clinical strategies

AC Shier, T Reichenbacher… - Journal of central …, 2013 - journals.sagepub.com
Attention deficit hyperactivity disorder (ADHD) is a common neurobehavioral disorder of
childhood that can result in significant functional impairment, and if not adequately treated …

Attention deficit hyperactivity disorder: clinical features and treatment options

CS Brown, SC Cooke - Cns Drugs, 1994 - Springer
Attention deficit hyperactivity disorder (ADHD) is a heterogeneous disorder of unknown
aetiology. It usually affects school-aged children with an estimated prevalence of 3 to 6 …

Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association …

B Bolea-Alamañac, DJ Nutt… - Journal of …, 2014 - journals.sagepub.com
Attention deficit hyperactivity disorder (ADHD) is a common condition with a high societal
burden. The present guidelines summarise current literature, generating expert consensus …